Loading...
XCNQ
NDAT
, Last price  
CAD
Name

nDatalyze Corp

Chart & performance

D1W1MN
XCNQ:NDAT chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
9.87%
Rev. 5Y
-68.25%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
-100.00%
0162,392531,167662,768424,928171,21596,3421,7140
Net income
-212k
L-61.77%
-304,000-256,963-36,598-698,527-1,173,481-1,232,000-155,601-554,476-211,976
CFO
-466k
L+114.35%
-261,396-216,39292,11720,745-1,125,357-1,023,796-217,464-466,136

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

nDatalyze Corp., established in 2018 and based in Calgary, Canada, specializes in developing innovative technology-driven solutions for the health sector. Its current primary focus includes the creation of an online mental health application for consumers, leveraging machine learning, alongside offering data licensing services. Additionally, the company manufactures and supplies specialized equipment for CO2 and alcohol-based essential oil extraction, catering primarily to medical cannabis cultivators. The organization adopted its current name in October 2021, having previously operated as MedXtractor Corp.
IPO date
Oct 24, 2019
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2026‑022025‑022024‑022023‑022022‑022021‑022020‑022019‑022018‑02
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT